American Psychiatric Association:
Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Rev .
Washington DC,
American Psychiatric Association.
2000.
American Psychiatric Associaiton Practice Guideline for the Treatment of Patients with Panic Disorder, 2nd ed., in American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders .
Arlington VA,
American Psychiatric Publishing Inc.
2009.
http://www.psychiatryonline.com/pracGuide/pracGuideHome.aspx
Angres
DH.
The Temperament and Character Inventory in addiction treatment. Focus .
2010; 8:187–98
Anton
RF.
Naltrexone for the management of alcohol dependence. NEJM .
2008; 359:715–21
Benedek
DM;
Friedman
MJ;
Zatzick
D;
Ursano
RJ.
Guideline Watch: Practice Guideline for the Treatment of Patients With Acute Stress Disorder and Posttraumatic Stress Disorder. Focus .
2009; 7:204–213
Bettens
K;
Sleegers
K;
Van Broeckhoven
C.
Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet .
2010
Apr 15;19(R1):R4–R11. Epub 2010 Apr 13.
Blum
N
et al..
Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: A randomized controlled trial and 1-year follow-up. Am J Psychiatry .
2008; 165:469
Brown
AS
et al..
Paternal age and risk of schizophrenia in adult offspring. Am J Psychiatry .
2002; 159:1528–1533
Burmeister
M.
Genetics of psychiatric disorders: a primer. FOCUS .
2006; 4:317–326
Cabaniss
D.
Personality disorders. FOCUS .
2005; 3:383–384
Calabrese
JR;
Huffman
RF;
White
RL;
Edwards
S;
Thompson
TR;
Ascher
JA;
Monaghan
ET;
Leadbetter
RA.
Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord .
2008; 10:323–333
Campbell
DB.
Advances and challenges in the genetics of autism. FOCUS .
2010; 8(3):339–349
Clark
LA.
Assessment and diagnosis of personality disorder: perennial issues and emerging reconceptualization. Annu Rev Psychol .
2007; 58:227–257
Clayton
AH;
Croft
HA;
Horrigan
JP;
Wightman
DS;
Krishen
A;
Richard
NE;
Modell
JG.
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry .
2006; 67:736–746
Dalman
C.
Advanced paternal age increases risk of bipolar disorder in offspring. Evid. Based Ment Health .
2009; 12:59
de Leon
J.
AmpliChip CYP450 Test: personalized medicine has arrived in psychiatry. Expert Rev. Mol. Diagn .
2006; 6:277–286
Dong
X;
Leppik
IE;
White
J;
Rarick
J.
Hyponatremia from oxcarbazepine and carbamazepine. Neurology .
2005; 65:1976–1978
Douglas
CJ.
Teaching supportive psychotherapy to psychiatric residents. Am J Psychiatry .
2008; 165:445–452
Dulcan
MK (ed). Dulcan's Textbook of Child and Adolescent Psychiatry .
Washington, DC.
American Psychiatric Publishing, Inc.
2010; 157–159.
Fanous
AH;
Kendler
KS.
Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Reprinted with permission in: FOCUS. 2006; 4:423–430. Molecular Psychiatry .
2005; 10:6–13
Faytout
M;
Tignol
J;
Swendsen
J;
Grabot
D;
Aouizerate
B;
Lépine
JP.
Social phobia, fear of negative evaluation and harm avoidance. Eur Psychiatry .
2007
Mar; 22(2):75–9
Ferrel
PB
Jr.;
McLeod
HL.
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenetics .
2008; 9:1543–1546
Fountoulakis
KN;
Grunze
H;
Panagiotidis
P;
Kaprinis
G.
Treatment of bipolar depression: an update. J Affect Disord .
2008; 109:21–34
Gabbard
GO (ed). Textbook of Psychotherapeutic Treatments .
Arlington VA:
American Psychiatric Publishing, Inc.
2009.
Gabbard
GO;
Horowitz
MJ.
Insight, transference Interpretation, and therapeutic change in the dynamic psychotherapy of borderline personality disorder. Am J Psychiatry
2009; 166: p 517
Gabbard
GO.
Long-Term Psychodynamic Psychotherapy: A Basic Text.
Washington DC,
American Psychiatric Publishing Inc.
2004; 59–77
Gabbard
GO.
Psychodynamic approaches to personality disorders. FOCUS .
2005; 3:363–367
Galanter
M;
Kleber
HD (eds). The American Psychiatric Publishing Textbook of Substance Abuse Treatment , 4th ed.
Arlington VA,
American Psychiatric Publishing Inc.
2008; 353–4
Haddad
PM;
Wieck
A.
Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs .
2004; 64:2291–2314
Hellerstein
DJ;
Markowitz
JC.
Developing supportive psychotherapy as evidence-based treatment. Am J Psychiatry .
2008; 165:1355-a-1356
Henry
NL;
Stearns
V;
Flockhart
DA;
Hayes
DF;
Riba
M.
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry .
2008; 165:1251–1255
Holliday
J;
Tchanturia
K;
Landau
S;
Collier
D;
Treasure
J.
Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry .
2005; 162:2269–2275
Hummelen
B;
Wilberg
T;
Pedersen
G;
Karterud
S.
The relationship between avoidant personality disorder and social phobia. Compr Psychiatry .
2007; 48:348–356
Jayadev
S;
Leverenz
JB;
Steinbart
E;
Stahl
J;
Klunk
W;
Yu
CE;
Bird
TD.
Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. Brain .
2010; 133(Pt 4):1143–54
Jefferson
JW.
Bupropion extended-release for depressive disorders. Expert Rev Neurother
2008; 8:715–722
Jolin
EM;
Weller
RA;
Weller
EB.
Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome). Curr Psychiatry Rep .
2009; 11(2):99–105.
Kaufman
DM. Clinical Neurology for Psychiatrists , 5th ed.
Philadelphia, WB
Saunders Company.
2001; 329–333
Kendler
KS;
Kuhn
JW;
Vittum
J;
Prescott
CA;
Riley
B.
The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry .
2005; 62:529–35
Kernberg
OF;
Michels
R.
Borderline personality disorder. Am J Psychiatry .
2009; 166:505–8
Kessing
LV
et al..
Suicide risk in patients treated with lithium. Arch Gen Psychiatry .
2005; 62:860–866
Koran
LM.
Obsessive-Compulsive Disorder: An update for the clinician. Focus .
2007; 5(3):299–313
Larimer
ME;
Palmer
RS;
Marlatt
GA.
Relapse prevention: an overview of Marlatt's cognitive-behavioral model. Alcohol Research and Health .
1999; 23:151–60
Leichsenring
F;
Salzer
S;
Jaeger
U;
Kächele
H;
Kreische
R;
Leweke
F
et al..
Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry .
2009; 166:875–881
Lewis
DA;
Moghaddam
B.
Cognitive dysfunction in schizophrenia: convergence of à;-aminobutyric acid and glutamate alterations. Arch Neurol
2006; 63:1372–6
Lieberman
JA;
Hsiao
JK.
Interpreting the results of the CATIE study. Psychiatr Serv .
2006; 57(1):139
Lieberman
JA;
Stroup
TS;
McEvoy
JP
et al..
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine .
2005; 353:1209–1223
Linehan
MM.
Dialectical behavior therapy for borderline personality disorder. Theory and method. Bull Menninger Clin .
1987; 51:261–76
Maldonado
JR.
Ask the Expert: Psychosomatic Medicine: Delirium. Focus .
2009; 7(3):336–42
Mannheimer
B;
Wettermark
B;
Lundberg
M;
Pettersson
H;
von Bahr
C;
Eliasson
E.
Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions. Br J Clin Pharmacol .
2010; 69(4):411–7
Markowitz
JC.
The clinical conduct of interpersonal psychotherapy. Focus .
2006; 4(2):179–84
Mason
BJ.
Acamprosate for alcohol dependence: An update for the clinician. FOCUS .
2006; 4:505–511
Mason
CE;
State
MW;
Moldin
SO.
Genome, Transcriptome, and Proteome. Charting a New Course to Understanding the Molecular Neurobiology of Mental Disorders. Chapter 1.11. in Sadock
BJ;
Sadock
VA;
Ruiz
P (eds): Kaplan and Sadock's Comprehensive Textbook of Psychiatry , 9th ed.
Philadelphia,
Lippincott Williams & Wilkins.
2009; 147–16
McGlashan
TH;
Grilo
CM;
Sanislow
CA;
Ralevski
E;
Morey
LC;
Gunderson
JG;
Skodol
AE;
Shea
MT;
Zanarini
MC;
Bender
D;
Stout
RL;
Yen
S;
Pagano
M.
Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. Am J Psychiatry .
2005; 162:883–889
Miklowitz
DJ.
Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry .
2008; 165:1408–1419
Mortberg
E;
Bejerot
S;
Aberg Wistedt
A.
Temperament and character dimensions in patients with social phobia: patterns of change following treatments? Psychiatry Res .
2007; 152(1):81–90. Epub 2007 Feb 27.
Mrazek
DA.
Psychiatric pharmacogenomics. FOCUS .
2006; 4:339–343
Oldham
JM;
Bender
DS;
Skodol
AE;
Dyck
IR;
Sanislow
CA;
Yen
S;
Grilo
CM;
Shea
MT;
Zanarini
MC;
Gunderson
JG;
McGlashan
TH.
Testing an APA practice guideline: Symptom-targeted medication utilization for patients with borderline personality disorder. Reprinted in FOCUS. 2005; 3:484–488. J Psychiatr Pract .
2004; 10(3):156–61
Ragins
M.
Should the CATIE study be a wake-up call? Psychiatric Services .
2005; 56:1489
Rapaport
MH.
Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Journal of Clinical Psychiatry .
2007; 68Suppl 8:42–6
Reed
RC;
Dutta
S.
Does it really matter when a blood sample for valproic acid concentration is taken following once-daily administration of divalproex-ER? Ther Drug Monit .
2006; 28:413–418
Reichenberg
A
et al.:
Advancing paternal age and autism. Arch Gen Psychiatry .
2006; 63:1026–1032
Robins
CJ;
Chapman
AL.
Dialectical behavior therapy: current status, recent developments, and future directions. J Pers Disord .
2004; 18:73–89
Rottman
BM;
Ahn
W;
Sanislow
CA;
Kim
NS.
Can clinicians recognize DSM-IV personality disorders from five-factor model descriptions of patient cases? Am J Psychiatry .
2009; 166:427–433
Rusch
N;
Hölzer
A;
Hermann
C;
Schramm
E;
Jacob
GA;
Bohus
M;
Lieb
K;
Corrigan
PW.
Self-stigma in women with borderline personality disorder and women with social phobia. J Nerv Ment Dis .
2006; 194(10):766–73
Rusch
N;
Lieb
K;
Göttler
I;
Hermann
C;
Schramm
E;
Richter
H;
Jacob
GA;
Corrigan
PW;
Bohus
M.
Shame and implicit self-concept in women with borderline personality disorder. Am J Psychiatry .
2007; 164:500–508
Sadock
BJ;
Sadock
VA (eds). Kaplan & Sadock's Synoposis of Psychiatry: Behavioral Sciences/Clinical Psychiatry , 10th ed.
Philadelphia,
Lippincott Williams & Wilkins.
2007.
Sadock
BJ;
Sadock
VA (eds). Kaplan & Sadock's Comprehensive Textbook of Psychiatry , 9th ed.
Philadelphia,
Lippinicott Williams & Wilkins.
2009.
Schatzberg
AF;
Cole
JO;
DeBattista
C (eds). Manual of Clinical Psychopharmacology , 7th ed.
Arlington VA,
American Psychiatric Publishing Inc.
2010; 340
Shearin
EN;
Linehan
MM.
Dialectical behavior therapy for borderline personality disorder: theoretical and empirical foundations. Acta Psychiatr Scand Suppl .
1994; 379:61–8
Silbersweig
D;
Clarkin
JF;
Goldstein
M;
Kernberg
OF;
Tuescher
O;
Levy
KN;
Brendel
G;
Pan
H;
Beutel
M;
Pavony
MT;
Epstein
J;
Lenzenweger
MF;
Thomas
KM;
Posner
MI;
Stern
E.
Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am J Psychiatry .
2007; 164:1832–1841
Sindrup
SH;
Brosen
K.
The pharmacogenetics of codeine hypoalgesia. Pharmacogenetics
1995; 5:335–346
Sipos
A;
Rasmussen
F;
Harrison
G;
Tynelius
P;
Lewis
G;
Leon
DA;
Gunnell
D.
Paternal age and schizophrenia: a population based cohort study. BMJ .
2004
Nov 6; 329(7474):1070
Smoller
JW;
Sheidley
BR;
Tsuang
MT.
Psychiatric Genetics: Applications in Clinical Practice1st ed.
American Psychiatric Publishing, Inc.
2008.
Stahl
SM.
Stahl's Essential Psychopharmacology, 3rd ed.
New York,
Cambridge University Press.
2008; 338–341, 845
Stein
MB;
Stein
DJ.
Social anxiety disorder. Lancet .
2008; 371:1115–1125
Stewart
SE;
Pauls
DL.
The genetics of obsessive compulsive disorder. FOCUS .
2010; 8(3):350–357
Thase
ME;
Macfadden
W;
Weisler
RH;
Chang
W;
Paulsson
B;
Khan
A;
Calabrese
JR.
Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (The Bolder II Study). J Clin Psychopharmacol .
2006; 26:600–609
Van Amelsvoort
T;
Bakshi
R.;
Devaux
CB;
Schwabe
S.
Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia .
1994; 35:181–188
Weissman
MM;
Markowitz
JC;
Klerman
GL.
Clinician's quick guide to interpersonal psychotherapy.
New York,
Oxford University Press.
2007.
Winston
A;
Rosenthal
RN;
Pinsker
H.
Introduction to Supportive Psychotherapy (Core Competencies in Psychotherapy), 1st ed.
Washington DC,
American Psychiatric Publishing Inc.
2004; 19
Wise
MG;
Rundell
JR (eds).
Clinical Manual of Psychosomatic Medicine: A Guide to Consultation-Liaison Psychiatry.
Arlington VA,
American Psychiatric Publishing Inc.
2005; 40–44
Wood
M;
Reavill
C.
Aripiprazole acts as a selective dopamine D2 receptor partial agonist. Expert Opin Investig Drugs .
2007; 16:771–775
Wright
JH.
Cognitive behavior therapy: Basic principles and recent advances. FOCUS .
2006; 4:173–178
Yudofsky
SC;
Hales
RE (eds). The American Psychiatric Publishing Textbook of Neuropsychiatry and Behavioral Sciences , 5th ed.
Arlington VA,
American Psychiatric Publishing Inc.
2008.
Zastrow
A;
Kaiser
S;
Stippich
C;
Walther
S;
Herzog
W;
Tchanturia
K;
Belger
A;
Weisbrod
M;
Treasure
J;
Friederich
HC.
Neural correlates of impaired cognitive-behavioral flexibility in anorexia nervosa. Am J Psychiatry .
2009; 166(5):608–16
Zisook
S.
Psychopharmacology: major depressive disorder. FOCUS .
2006; 4:484–486